Pharmaceutical Standardization and Analytical Evaluation of Madurantak Vati Prepared with Guduchi Satva
DOI:
https://doi.org/10.47070/ayushdhara.v13i1.2563Keywords:
Madhurantak Vati, Guduchi Satva, Pharmaceutical Standardization, Analytical Evaluation, Quality Control, Tinospora cordifolia, Enteric FeverAbstract
Standardization of Ayurvedic formulations is crucial for ensuring quality, safety, and therapeutic efficacy. Madhurantak vati consists of ingredients like Guduchi, Tulsi etc and is indcated in enteric fever. Considering the role of Madhurantak vati in infectious conditions, it was decided to carry out anti-microbial study of these formulations against microorganisms namely Salmonella typhi, Salmonella Paratyphi, E coli and Streptococcus pyogens. Incorporation of Guduchi Satva, derived from Tinospora cordifolia, is believed to enhance its immunomodulatory properties. Scientific pharmaceutical and analytical validation of this preparation is essential for quality assurance. Methods: Madhurantak Vati was prepared according to classical Ayurvedic references using authenticated raw materials and standardized Guduchi Satva. Pharmaceutical standardization included organoleptic evaluation (color, odor, taste, texture) and tablet parameters such as uniformity of weight, hardness, friability, and disintegration time. Analytical evaluation involved physicochemical parameters including loss on drying, total ash, acid-insoluble ash, water- and alcohol-soluble extractive values, and pH. Preliminary phytochemical screening and chromatographic profiling (TLC/HPTLC) were performed to establish characteristic fingerprints. Results: The formulation showed satisfactory organoleptic properties and complied with acceptable pharmacopeial limits for tablet evaluation parameters. Physicochemical values were within permissible ranges, indicating purity and stability. Discussion: The study establishes preliminary pharmaceutical and analytical standards for Madhurantak Vati prepared with Guduchi Satva. These findings provide a scientific basis for ensuring batch-to-batch consistency, safety, and therapeutic reliability of the formulation.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 AYUSHDHARA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
